ALLMedicine™ Astroblastoma Center
Research & Reviews 24 results
https://doi.org/10.1007/s00381-021-05289-3 10.1002/pbc.28627 10.1111/nan.12701 10.18632/oncotarget.12188 10.1007/s10014-020-00372-0 10.2176/nmccrj.cr.2020-0028 10.1111/bpa.12565 10.1016/j.acthis.2019.05.006 10.1186/s40478-020-00984-9 10.1186/s40478-019-0689-3 10.1111/bpa.12832 10.1007/s00381-017-3410-5 10.1007/s10014-019-00346-x 10.1093/hmg/ddaa231 10.1111/neup.12514 10.1016/j.cell.2016.01.015 10.1186/s40478-019-0834-z 10.1007/s10014-021-00401-6 10.1111/bpa.12561 10.3233/CBM-160235
Child's Nervous System : ChNS : Official Journal of the I... Sari R, Altinoz MA et. al.
Jul 17th, 2021 - Astroblastoma, MN1-altered (old name: high-grade neuroepithelial tumor/HGNET with MN1 alteration) is a recently described central nervous system tumor mostly affecting pediatric patients and profoundly young girls. Differential pathological diagno...
Neuropathology and Applied Neurobiology; Chadda KR, Holland K et. al.
Feb 4th, 2021 - In a case of astroblastoma, methylation analysis was uninformative, with no clustering with known CNS-HGNET-MN1 cases. Whole genome sequencing however identified a novel MN1-GTSE1 gene fusion (image), confirming the diagnosis of astroblastoma, as ...
Child's Nervous System : ChNS : Official Journal of the I... Gupta S, Rangari KV et. al.
Jan 4th, 2020 - Angiocentric glioma (AG) is a relatively uncommon clinico-pathological entity that presents in childhood. Angiocentric glioma displays various histopathological features which resemble cortical ependymoma, astroblastoma, and pilomyxoid astrocytoma...
Neuropathology and Applied Neurobiology; Yamasaki K, Nakano Y et. al.
Dec 21st, 2019 - CNS high-grade neuroepithelial tumour with an MN1 alteration (HGNET-MN1) is a new entity of CNS brain tumour recently described by Sturm et al. . In addition to its distinct methylation signature, MN1 alteration is a feature of HGNET-MN1, and o...
The Oncologist; Boisseau W, Euskirchen P et. al.
Jul 28th, 2019 - Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations.|2019|Boisseau W,Euskirchen P,Mokhtari K,Dehais C,Touat M,|